Results for vaximmune. Search took 0.14 seconds.
Merck Licenses Coley Pharma's VaxImmune for $4 Million
in The Biotech Weblog, on April 13, 2007
...
Merck & Co., Inc. has licensed Coley Pharmaceutical 's VaxImmune (TM) vaccine adjuvant for an upfront license fee of $4 million, and milestone fess of up to $33 million plus royalties....



